Celldex Therapeutics
CLDX
CLDX
53 hedge funds and large institutions have $14.9M invested in Celldex Therapeutics in 2019 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 3 increasing their positions, 39 reducing their positions, and 41 closing their positions.
Holders
53
Holders Change
-32
Holders Change %
-37.65%
% of All Funds
1.15%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
11
Increased
3
Reduced
39
Closed
41
Calls
$508K
Puts
–
Net Calls
+$508K
Net Calls Change
+$495K
Top Buyers
1 |
1
BlackRock
New York
|
$1.49M |
2 |
BCM
2
Bridgeway Capital Management
Houston,
Texas
|
$609K |
3 |
3
Renaissance Technologies
New York
|
$2.68M |
4 |
4
D.E. Shaw & Co
New York
|
$520K |
5 |
5
Vanguard Group
Malvern,
Pennsylvania
|
$2.4M |